Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient

Robert M Esterl, Navyash Gupta, Paul J. Garvin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Blindness is an extremely rare complication of cyclosporine neurotoxicity. In all 10 cases in the literature, this form of blindness is completely reversible with the reduction or withdrawal of cyclosporine. We describe the first case of sudden, complete, and permanent blindness within 36 h after administration of intravenous cyclosporine in a kidney-pancreas transplant recipient.

Original languageEnglish (US)
Pages (from-to)259-266
Number of pages8
JournalClinical Neuropharmacology
Volume19
Issue number3
StatePublished - 1996

Fingerprint

Blindness
Cyclosporine
Pancreas
Kidney
Intravenous Administration
Transplant Recipients

Keywords

  • Blindness
  • Cyclosporine
  • Kidney-pancreas transplant
  • Neurotoxicity

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient. / Esterl, Robert M; Gupta, Navyash; Garvin, Paul J.

In: Clinical Neuropharmacology, Vol. 19, No. 3, 1996, p. 259-266.

Research output: Contribution to journalArticle

@article{cc3aa15770c549288c2020a4efea6c7c,
title = "Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient",
abstract = "Blindness is an extremely rare complication of cyclosporine neurotoxicity. In all 10 cases in the literature, this form of blindness is completely reversible with the reduction or withdrawal of cyclosporine. We describe the first case of sudden, complete, and permanent blindness within 36 h after administration of intravenous cyclosporine in a kidney-pancreas transplant recipient.",
keywords = "Blindness, Cyclosporine, Kidney-pancreas transplant, Neurotoxicity",
author = "Esterl, {Robert M} and Navyash Gupta and Garvin, {Paul J.}",
year = "1996",
language = "English (US)",
volume = "19",
pages = "259--266",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient

AU - Esterl, Robert M

AU - Gupta, Navyash

AU - Garvin, Paul J.

PY - 1996

Y1 - 1996

N2 - Blindness is an extremely rare complication of cyclosporine neurotoxicity. In all 10 cases in the literature, this form of blindness is completely reversible with the reduction or withdrawal of cyclosporine. We describe the first case of sudden, complete, and permanent blindness within 36 h after administration of intravenous cyclosporine in a kidney-pancreas transplant recipient.

AB - Blindness is an extremely rare complication of cyclosporine neurotoxicity. In all 10 cases in the literature, this form of blindness is completely reversible with the reduction or withdrawal of cyclosporine. We describe the first case of sudden, complete, and permanent blindness within 36 h after administration of intravenous cyclosporine in a kidney-pancreas transplant recipient.

KW - Blindness

KW - Cyclosporine

KW - Kidney-pancreas transplant

KW - Neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=0029880893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029880893&partnerID=8YFLogxK

M3 - Article

C2 - 8726545

AN - SCOPUS:0029880893

VL - 19

SP - 259

EP - 266

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 3

ER -